Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ticrynafen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.78 |
| ▸ | GSTP1 | P09211 | 13/20 | 0.73 |
| ▸ | GSTA1 | P08263 | 7/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.73 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | RECQL | P46063 | 1/20 | 0.73 |
| ▸ | MAP2K6 | P52564 | 1/20 | 0.73 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.73 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.73 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.73 |
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ticrynafen SCHEMBL123608 | 0.88 | CYP2C9 (1.00) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ticrynafen SCHEMBL30232637 | 0.88 | CYP2C9 (1.00) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ethacrynic Acid SCHEMBL29384243 | 0.86 | GSTP1 (1.00) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ethacrynic Acid SCHEMBL9108011 | 0.86 | GSTP1 (1.00) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ethacrynic Acid SCHEMBL26353 | 0.86 | GSTP1 (1.00) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ethacrynic Acid SCHEMBL2482896 | 0.84 | GSTP1 (0.97) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ethacrynic Acid SCHEMBL3713733 | 0.84 | GSTP1 (0.97) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| Ethacrynic Acid SCHEMBL905726 | 0.84 | GSTP1 (0.97) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| SCHEMBL11358120 | 0.80 | CYP2C9 (0.79) | CYP2C9GSTP1GSTA1MEN1ABCC3 | |
| SCHEMBL13823284 | 0.80 | CYP2C9 (0.74) | CYP2C9MEN1ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107412173-A | Anti-distort solid oral dosage form | 普渡制药公司 | 2017-12-01 | — | — | CN | disclosed |
| US-20120148691-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION | GENEREX PHARMACEUTICALS, INC. | 2012-06-14 | — | — | US | disclosed |
| EP-2440220-A1 | COMPOSITIOINS AND PREPARATION METHODS OF COMPOSITIONS FOR PREVENTION AND TREATMENT OF HYPERTENSION | Generex Pharmaceuticals, Inc. (CN) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010143059-A1 | COMPOSITIOINS AND PREPARATION METHODS OF COMPOSITIONS FOR PREVENTION AND TREATMENT OF HYPERTENSION | GENEREX PHARMACEUTICALS, INC. (CN) | 2010-12-16 | — | — | WO | disclosed |